{"id":"https://openalex.org/W3128080784","doi":"https://doi.org/10.1681/asn.2020081150","title":"Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study","display_name":"Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study","alternate_titles":[],"publication_year":2021,"publication_date":"2021-02-10","ids":{"openalex":"https://openalex.org/W3128080784","doi":"https://doi.org/10.1681/asn.2020081150","mag":"3128080784","pmid":"https://pubmed.ncbi.nlm.nih.gov/33568383","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7920165"},"language":"en","primary_location":{"id":"doi:10.1681/asn.2020081150","doi":"https://doi.org/10.1681/asn.2020081150","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2020081150","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3128080784"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7920165/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016502106","display_name":"Steven N. Fishbane","orcid":"https://orcid.org/0000-0002-2238-8574","observed_orcids":["https://orcid.org/0000-0002-2238-8574"]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]},{"id":"https://openalex.org/I139290212","display_name":"Hofstra University","ror":"https://ror.org/03pm18j10","country_code":"US","type":"education","lineage":["https://openalex.org/I139290212"]},{"id":"https://openalex.org/I4210106353","display_name":"Donald & Barbara Zucker School of Medicine at Hofstra/Northwell","ror":"https://ror.org/01ff5td15","country_code":"US","type":"education","lineage":["https://openalex.org/I1302444339","https://openalex.org/I139290212","https://openalex.org/I4210106353"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven Fishbane","raw_affiliation_strings":["Department of Medicine, Zucker School of Medicine at Hofstra/Northwell Health, Great Neck, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Zucker School of Medicine at Hofstra/Northwell Health, Great Neck, New York","institution_ids":["https://openalex.org/I1302444339","https://openalex.org/I139290212","https://openalex.org/I4210106353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103797259","display_name":"Mohamed A. El-Shahawy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mohamed A. El-Shahawy","raw_affiliation_strings":["Department of Medicine, Keck-University of Southern California School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Keck-University of Southern California School of Medicine, Los Angeles, California","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038855428","display_name":"Roberto Pecoits\u2010Filho","orcid":"https://orcid.org/0000-0002-0255-6710","observed_orcids":["https://orcid.org/0000-0002-0255-6710"]},"institutions":[{"id":"https://openalex.org/I176838256","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1","ror":"https://ror.org/02x1vjk79","country_code":"BR","type":"education","lineage":["https://openalex.org/I176838256"]},{"id":"https://openalex.org/I4210137387","display_name":"Arbor Research Collaborative for Health","ror":"https://ror.org/043qmbk61","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210137387"]}],"countries":["BR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roberto Pecoits-Filho","raw_affiliation_strings":["Arbor Research Collaborative for Health, Ann Arbor, Michigan","School of Medicine, Pontifical Catholic University of Parana, Curitiba, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arbor Research Collaborative for Health, Ann Arbor, Michigan","institution_ids":["https://openalex.org/I4210137387"]},{"raw_affiliation_string":"School of Medicine, Pontifical Catholic University of Parana, Curitiba, Brazil","institution_ids":["https://openalex.org/I176838256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002814767","display_name":"Bui Pham Van","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I18550681","display_name":"Pham Ngoc Thach University of Medicine","ror":"https://ror.org/003g49r03","country_code":"VN","type":"education","lineage":["https://openalex.org/I18550681"]}],"countries":["VN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bui Pham Van","raw_affiliation_strings":["Department of Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam","institution_ids":["https://openalex.org/I18550681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080026860","display_name":"Mark T. Houser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark T. Houser","raw_affiliation_strings":["Global Medicines Development, Biopharmaceuticals Research & Development, AstraZeneca Gaithersburg, Gaithersburg, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medicines Development, Biopharmaceuticals Research & Development, AstraZeneca Gaithersburg, Gaithersburg, Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036890206","display_name":"Lars Frison","orcid":"https://orcid.org/0000-0003-0425-4078","observed_orcids":["https://orcid.org/0000-0003-0425-4078"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Frison","raw_affiliation_strings":["Biostatistics, Biopharmaceuticals Research & Development, AstraZeneca Gothenburg, M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, Biopharmaceuticals Research & Development, AstraZeneca Gothenburg, M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025264844","display_name":"Dustin J. Little","orcid":"https://orcid.org/0000-0002-4201-0237","observed_orcids":["https://orcid.org/0000-0002-4201-0237"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dustin J. Little","raw_affiliation_strings":["Global Medicines Development, Biopharmaceuticals Research & Development, AstraZeneca Gaithersburg, Gaithersburg, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medicines Development, Biopharmaceuticals Research & Development, AstraZeneca Gaithersburg, Gaithersburg, Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025170201","display_name":"Nicolas Jose Guzman","orcid":"https://orcid.org/0000-0002-9503-0530","observed_orcids":["https://orcid.org/0000-0002-9503-0530"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicolas J. Guzman","raw_affiliation_strings":["Global Medicines Development, Biopharmaceuticals Research & Development, AstraZeneca Gaithersburg, Gaithersburg, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medicines Development, Biopharmaceuticals Research & Development, AstraZeneca Gaithersburg, Gaithersburg, Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046497650","display_name":"Pablo E. P\u00e9rgola","orcid":"https://orcid.org/0000-0002-5876-894X","observed_orcids":["https://orcid.org/0000-0002-5876-894X"]},"institutions":[{"id":"https://openalex.org/I4210157924","display_name":"Renal Associates P. A.","ror":"https://ror.org/04wc1v131","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210157924"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pablo E. Pergola","raw_affiliation_strings":["Renal Associates PA, San Antonio, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Associates PA, San Antonio, Texas","institution_ids":["https://openalex.org/I4210157924"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":22.1815,"has_fulltext":false,"cited_by_count":212,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99722367,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"32","issue":"3","first_page":"737","last_page":"755"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/roxadustat","display_name":"roxadustat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pre-dialysis-patients","display_name":"predialysis","score":0.9649999737739563},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor","display_name":"hypoxia-inducible factor prolyl hydroxylase inhibitor","score":0.9629999995231628},{"id":"https://openalex.org/keywords/hemoglobin-increase","display_name":"hemoglobin increase","score":0.7950000166893005},{"id":"https://openalex.org/keywords/red-blood-cell-transfusion","display_name":"red blood cell transfusion","score":0.8500000238418579},{"id":"https://openalex.org/keywords/iron-homeostasis","display_name":"iron homeostasis","score":0.871999979019165},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.765999972820282},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3930000066757202},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6620000004768372},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.5}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7226331233978271},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.6743253469467163},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.5787692666053772},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5605526566505432},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.47710710763931274},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47327136993408203}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023381","descriptor_name":"Endpoint Determination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064799","descriptor_name":"Hypoxia-Inducible Factor-Proline Dioxygenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D064800","descriptor_name":"Prolyl-Hydroxylase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D064800","descriptor_name":"Prolyl-Hydroxylase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1681/asn.2020081150","doi":"https://doi.org/10.1681/asn.2020081150","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2020081150","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7920165","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7920165/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Am Soc Nephrol","raw_type":"Text"},{"id":"pmid:33568383","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33568383","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology : JASN","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7920165","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7920165/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Am Soc Nephrol","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1551691154","https://openalex.org/W1964685535","https://openalex.org/W1970297185","https://openalex.org/W1984393349","https://openalex.org/W1986769675","https://openalex.org/W1987058058","https://openalex.org/W1987601001","https://openalex.org/W1998943227","https://openalex.org/W2040029744","https://openalex.org/W2040031153","https://openalex.org/W2040363869","https://openalex.org/W2046124938","https://openalex.org/W2049123117","https://openalex.org/W2064224521","https://openalex.org/W2073271820","https://openalex.org/W2084225019","https://openalex.org/W2100707147","https://openalex.org/W2109081740","https://openalex.org/W2124116160","https://openalex.org/W2134487085","https://openalex.org/W2136098489","https://openalex.org/W2152271789","https://openalex.org/W2152811977","https://openalex.org/W2161759333","https://openalex.org/W2321377008","https://openalex.org/W2339445416","https://openalex.org/W2572770153","https://openalex.org/W2593244426","https://openalex.org/W2736021559","https://openalex.org/W2783722462","https://openalex.org/W2801651391","https://openalex.org/W2899694001","https://openalex.org/W2908310794","https://openalex.org/W2915146394","https://openalex.org/W2915967003","https://openalex.org/W2918092070","https://openalex.org/W2963534431","https://openalex.org/W2964863420","https://openalex.org/W2966783741","https://openalex.org/W2977297734","https://openalex.org/W2981015842","https://openalex.org/W3001009832","https://openalex.org/W3012262428","https://openalex.org/W3030888994","https://openalex.org/W3037659459","https://openalex.org/W6902847393"],"related_works":["https://openalex.org/W3037659459","https://openalex.org/W4396996775","https://openalex.org/W3155406879","https://openalex.org/W4396994106","https://openalex.org/W2929594700","https://openalex.org/W4396996588","https://openalex.org/W2963534431","https://openalex.org/W3130258858","https://openalex.org/W3188004162","https://openalex.org/W3012148201"],"abstract_inverted_index":{"Significance":[0],"Statement":[1],"Anemia":[2,411],"is":[3],"untreated":[4],"in":[5,80,123,204,250,291,372,412],"many":[6],"patients":[7,21,124,133,166,219,282,373],"with":[8,61,125,134,167,265,275,283,303,313,342,374,386],"non\u2013dialysis-dependent":[9,69,126,135,168,375],"CKD.":[10,70,127],"Barriers":[11],"to":[12,78,106,177,263,273,301,311,335,392,409],"the":[13,50,64,85,118,188,320,379],"use":[14],"of":[15,40,66,68,121,213,322,394,407],"current":[16],"anemia":[17,67,122,130],"therapies":[18,131],"among":[19],"such":[20],"include":[22],"parenteral":[23],"administration":[24],"that":[25,73,111,393],"may":[26,113,137],"require":[27,138],"a":[28,31,44],"medical":[29,141],"visit,":[30],"requirement":[32],"for":[33,63,87,117,132,220,244,381],"iron":[34,155],"repletion,":[35],"and":[36,83,99,140,153,172,233,344,362,377,400,404],"potentially":[37],"increased":[38,370],"risk":[39,321],"cardiovascular":[41],"events.":[42,222],"In":[43,158],"phase":[45,161],"3":[46,162],"placebo-controlled":[47],"international":[48],"study,":[49,163],"authors":[51],"compared":[52],"roxadustat,":[53],"an":[54,101,144,387],"oral":[55,119,145,180],"hypoxia-inducible":[56,146],"factor":[57,147],"prolyl":[58,148],"hydroxylase":[59,149],"inhibitor,":[60,150],"placebo":[62,79],"treatment":[65],"They":[71],"report":[72],"roxadustat":[74,112,181,232,266,304,343],"was":[75,95,199,241,254,295],"statistically":[76],"superior":[77],"increasing":[81],"hemoglobin":[82,173,192,205,240,251,292,371],"reduced":[84,319,378],"need":[86,380],"red":[88,323,382],"blood":[89,324,383],"cell":[90,325,384],"transfusion.":[91],"The":[92,194,224,247,337],"drug":[93],"also":[94],"generally":[96],"well":[97],"tolerated":[98],"had":[100],"adverse":[102,221,340,388],"event":[103,389],"profile":[104,390],"comparable":[105,391],"placebo.":[107,183,237,395],"These":[108],"findings":[109],"indicate":[110],"be":[114],"clinically":[115],"useful":[116],"management":[120],"Background":[128],"Current":[129],"CKD":[136,169,376],"injection":[139],"visits.":[142],"Roxadustat,":[143],"stimulates":[151],"erythropoiesis":[152],"improves":[154],"homeostasis.":[156],"Methods":[157],"this":[159],"double-blind":[160],"we":[164],"randomized":[165],"stages":[170],"3\u20135":[171],"<10.0":[174],"g/dl":[175,243,256,269,297,307],"(1:1)":[176],"thrice-weekly":[178],"70-mg":[179],"or":[182],"Doses":[184],"were":[185,347],"titrated":[186],"throughout":[187],"study":[189,225],"based":[190],"on":[191,417],"levels.":[193],"primary":[195],"efficacy":[196],"end":[197],"point":[198],"mean":[200,248,289],"change":[201,249,290],"from":[202,252,293],"baseline":[203,239,253,284,294],"averaged":[206],"over":[207],"weeks":[208],"28\u201352":[209],"versus":[210,267,305,350,356,360,365],"placebo,":[211,276,314,345],"irrespective":[212],"rescue":[214],"therapy":[215],"use.":[216],"We":[217],"assessed":[218],"Results":[223],"included":[226],"2781":[227],"patients,":[228],"1393":[229],"who":[230,235],"received":[231,236],"1388":[234],"Mean":[238],"9.1":[242],"both":[245],"groups.":[246],"1.75":[255,296],"(95%":[257,270,298,308],"confidence":[258],"interval":[259],"[95%":[260],"CI],":[261],"1.68":[262],"1.81)":[264],"0.40":[268],"CI,":[271,299,309,333],"0.33":[272],"0.47)":[274],"(":[277,315],"P":[278,316],"<0.001).":[279,317],"Among":[280],"411":[281],"elevated":[285],"high-sensitivity":[286],"C-reactive":[287],"protein,":[288],"1.58":[300],"1.92)":[302],"0.62":[306],"0.44":[310],"0.80)":[312],"Roxadustat":[318,368,408],"transfusion":[326],"by":[327],"63%":[328],"(hazard":[329],"ratio,":[330],"0.37;":[331],"95%":[332],"0.30":[334],"0.44).":[336],"most":[338],"common":[339],"events":[341],"respectively,":[346],"ESKD":[348],"(21.0%":[349],"20.5%),":[351],"urinary":[352],"tract":[353],"infection":[354],"(12.8%":[355],"8.0%),":[357],"pneumonia":[358],"(11.9%":[359],"9.4%),":[361],"hypertension":[363],"(11.5%":[364],"9.1%).":[366],"Conclusions":[367],"effectively":[369],"transfusion,":[385],"Clinical":[396],"Trial":[397],"registry":[398],"name":[399],"registration":[401],"number:":[402],"Safety":[403],"Efficacy":[405],"Study":[406],"Treat":[410],"Patients":[413],"With":[414],"CKD,":[415],"Not":[416],"Dialysis,":[418],"NCT02174627":[419]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3128080784","counts_by_year":[{"year":2026,"cited_by_count":37},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":36},{"year":2023,"cited_by_count":42},{"year":2022,"cited_by_count":44},{"year":2021,"cited_by_count":26}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2021-02-15T00:00:00"}
